Idiopathic Intracranial Hypertension: Prognostic Factors and Multidisciplinary Management

Claire Chagot, Marie Blonski, Jean‐Loup Machu, Serge Bracard, Jean‐Christophe Lacour, Sébastien Richard

Journal of Obesity · 2017 · 31 citations · 44 references

DOIFull text

Open access

Concepts

Abstract

Background . Idiopathic intracranial hypertension (IIH) mostly affects young obese women and can lead to permanent visual impairment. However, prognostic factors and therapeutic strategy remain unclear. Methods . We retrospectively collected data from all patients diagnosed and managed for IIH in our university center from January 2001 to December 2016. Results . Seventy-nine patients were diagnosed with IIH. Bilateral transverse sinus stenosis (TSS) was found in 74% of the population. Visual outcome at 6 months was poor for 46% of patients, including all patients presenting weight gain of at least 5% since diagnosis (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn fontstyle="italic">0.001</mml:mn></mml:math>), whereas mean body mass index at diagnosis was not different between patients with poor versus good outcome (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mn fontstyle="italic">32.9</mml:mn><mml:mo>±</mml:mo><mml:mn fontstyle="italic">7.7</mml:mn></mml:math> versus 34.6 ± 9.4 kg·m −2 ). Other significant factors of poor prognosis were bilateral TSS (OR = 5.2; 95 CI: 1.24–24.9; <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle="italic">0.024</mml:mn></mml:math>). Thirteen patients with poor outcome after 6-month assessment underwent unilateral TSS stenting leading to visual improvement in 11 cases. Conclusion . Weight gain, rather than initial weight, emerged as the leading factor of poor visual outcome in patients with IIH, followed by presence of bilateral TSS. Consequently, first-line treatment must include dietary measures to control weight. Unilateral stenting appears to be a safe second-line treatment option for patients with bilateral TSS.

References

44